Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children
Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children
Recruiting · NCT06306196 · Registry updated 2025-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children | Digestive System Diseases, Infections, RNA Virus Infections, hepatitis, hepatitis E virus infection, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 2 | 2025-04-29 | NCT06306196 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bill and Melinda Gates Foundation | 67 |
| International Vaccine Institute | 10 |
| Xiamen Innovax Biotech Co., Ltd | 8 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Be Part Research | Paarl | South Africa | 1 |
| MeCRU Clinical Research Unit | Ga-Rankuwa | South Africa | 1 |
| Newtown Clinical Research Centre | Johannesburg | South Africa | 2 |